RC
MGNX icon

Rangeley Capital’s MacroGenics MGNX Stock Holding History

Rangeley Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.1K Sell
21,500
-8,720
-29% -$18.6K 0.06% 128
2025
Q4 		$48.7K Hold
30,220
– – 0.04% 116
2025
Q3 		$50.8K Buy
30,220
+3,220
+12% +$5.21K 0.04% 119
2025
Q2 		$32.7K Buy
+27,000
New +$39.2K 0.04% 66

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Rangeley Capital's MGNX Position: Q1 2026 in Review

Rangeley Capital reduced its MacroGenics (MGNX) stake by 29% in Q1 2026, selling an estimated $18.6K and leaving 21,500 shares worth $62.1K. The position accounts for 0.06% of the portfolio, ranked #128.

Rangeley Capital first reported a position in MGNX in Q2 2025 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Rangeley Capital held 21,500 shares of MacroGenics worth $62.1K as of Q1 2026.
  • Rangeley Capital sold 8,720 MacroGenics shares in Q1 2026, an estimated $18.6K.
  • MacroGenics made up 0.06% of Rangeley Capital's portfolio in Q1 2026, its #128 holding.
  • Rangeley Capital first reported a position in MacroGenics in Q2 2025 and has held it in 4 quarters since.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.